Biosimilar Newsletter Archive

  1. 07.25.24 -- Using The ADKAR Model In Biopharma Change Management 7/25/2024
    07/25/24 Biosimilar Development Newsletter
  2. 07.18.24 -- Maximize Bioprocessing Uptime With Comprehensive Service Solutions 7/18/2024

    07/18/24 Biosimilar Development Newsletter

  3. 07.18.24 -- SFMEA: An Alternative Approach For Analyzing Risks 7/18/2024
    07/18/24 Biosimilar Development Newsletter
  4. 07.11.24 -- Where's The Case For Generative AI In Biopharma Manufacturing? 7/11/2024
    07/11/24 Biosimilar Development Newsletter
  5. 07.07.24 -- Does Flow Play A Role In Protein Aggregation? 7/7/2024
    07/07/24 Biosimilar Development Newsletter
  6. 07.03.24 -- Does Flow Play A Role In Protein Aggregation? 7/3/2024
    07/03/24 Biosimilar Development Newsletter
  7. 06.27.24 -- Novel mAbs? Be Empowered To Innovate 6/27/2024

    06/27/24 Biosimilar Development Newsletter

  8. 06.27.24 -- B.C.'s Biosimilar Initiative Saves Money, Reinvests To Expand Drug Coverage 6/27/2024
    06/27/24 Biosimilar Development Newsletter
  9. 06.25.24 -- Smart Investment, Big Returns: Optimizing Cell Culture For Efficiency And Value 6/25/2024

    06/25/24 Biosimilar Development Newsletter

  10. 06.20.24 -- Achieving Seamless Tech Transfer With Your CDMO 6/20/2024

    06/20/24 Biosimilar Development Newsletter